X4 Pharmaceuticals

X4 Pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases and cancer.

Select Venture Capital & Financial Partners

Cormorant Asset Management Thynk Capital

www.x4pharma.com